Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 2 × Polyps × Gastrointestinal × Clear all

Phase

Phase NA 34 Phase 4 4 Phase 2/3 4 Phase 3 2 Phase 1 2 Phase 2 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Colorectal Neoplasms 1277 Pancreatic Neoplasms 813 Carcinoma, Hepatocellular 775 Stomach Neoplasms 747 Rectal Neoplasms 558 Esophageal Neoplasms 449 Colonic Neoplasms 412 Esophageal Squamous Cell Carcinoma 272 Neoplasm Metastasis 263 Cholangiocarcinoma 246 Liver Neoplasms 217 Neoplasms 197 Biliary Tract Neoplasms 176 Adenocarcinoma Of Esophagus 138 Gastrointestinal Stromal Tumors 105 Gallbladder Neoplasms 95 Adenocarcinoma 94 Breast Neoplasms 89 Gastrointestinal Neoplasms 87 Carcinoma, Non-Small-Cell Lung 86 Bile Duct Neoplasms 69 Sarcoma 67 Lung Neoplasms 63 Ovarian Neoplasms 59 Anus Neoplasms 58 Melanoma 54 Uterine Cervical Neoplasms 50 Carcinoma 48 Digestive System Neoplasms 42 Prostatic Neoplasms 39

Interventions

eicosapentaenoic acid ethyl ester 1 Fatty Acids, Omega-3 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT03661047 2021-11-17

OMICC

Massachusetts General Hospital

Phase 2 Withdrawn

Gastrointestinal

Colonic Neoplasms, Polyps, Colorectal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡